News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Haqq Christopher
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/12/2023 |
3
| Haqq Christopher (See Remarks) has filed a Form 3 on Elicio Therapeutics, Inc. |
08/13/2021 |
4
| Haqq Christopher (Former Director) has filed a Form 4 on Surrozen, Inc./DE
Txns:
| Granted 30,000 shares
@ $0 Disposed/sold 30,000 options to buy
@ $0 |
|
11/18/2020 |
3
| Haqq Christopher (Director) has filed a Form 3 on Consonance-HFW Acquisition Corp. |
02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/15/2018 |
4
| Haqq Christopher (EVP, R&D & Chief Scientific Of) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 775 shares
@ $33.81, valued at
$26.2k
|
|
09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/25/2018 |
4
| Haqq Christopher (EVP, R&D & Chief Scientific Of) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 14,069 shares
@ $39.74, valued at
$559.1k
Sold 3,931 shares
@ $40.53, valued at
$159.3k
Sold 10,000 shares
@ $40.26, valued at
$402.6k
Sold 3,500 shares
@ $41.23, valued at
$144.3k
|
|
08/16/2018 |
4
| Haqq Christopher (EVP, R&D & Chief Scientific Of) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 775 shares
@ $37.54, valued at
$29.1k
|
|
05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/27/2018 |
4
| Haqq Christopher (EVP, R&D & Chief Scientific Of) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 17,227 shares
@ $39.76, valued at
$684.9k
Sold 1,100 shares
@ $40.29, valued at
$44.3k
|
|
02/20/2018 |
4
| Haqq Christopher (EVP, R&D & Chief Scientific Of) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Exercised 553 restricted stock units
@ $0 |
|
02/12/2018 |
4
| Haqq Christopher (EVP, R&D & Chief Scientific Of) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Paid exercise price by delivering 4,925 shares
@ $41.7, valued at
$205.4k
|
|
02/08/2018 |
4
| Haqq Christopher (EVP, R&D & Chief Scientific Of) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Granted 17,500 shares
@ $0 Paid exercise price by delivering 4,426 shares
@ $35.8, valued at
$158.5k
Granted 35,000 options to buy
@ $35.8, valued at
$1.3M
|
|
11/17/2017 |
4
| Haqq Christopher (EVP, R&D & Chief Scientific Of) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 1,604 shares
@ $13.36, valued at
$21.4k
Exercised 829 restricted stock units
@ $0 |
|
10/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2017 |
4
| Haqq Christopher (EVP, R&D & Chief Scientific Of) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 6,000 shares
@ $12.65, valued at
$75.9k
|
|
04/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/23/2016 |
4
| Haqq Christopher (Chief Medical Officer) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Granted 90,000 shares
@ $0 |
|
08/17/2016 |
4
| Haqq Christopher (Chief Medical Officer) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 400 shares
@ $21.7, valued at
$8.7k
Sold 946 shares
@ $22.58, valued at
$21.4k
Exercised 829 restricted stock units
@ $0 |
|
05/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/18/2016 |
4
| Haqq Christopher (Chief Medical Officer) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 3,208 shares
@ $15.43, valued at
$49.5k
Exercised 829 restricted stock units
@ $0 |
|
|
|